1
|
Suthaharan P, Thompson SL, Rossi-Goldthorpe RA, Rudebeck PH, Walton ME, Chakraborty S, Noonan MP, Costa VD, Murray EA, Mathys CD, Groman SM, Mitchell AS, Taylor JR, Corlett PR, Chang SWC. Lesions to the mediodorsal thalamus, but not orbitofrontal cortex, enhance volatility beliefs linked to paranoia. Cell Rep 2024; 43:114355. [PMID: 38870010 PMCID: PMC11231991 DOI: 10.1016/j.celrep.2024.114355] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2023] [Revised: 04/13/2024] [Accepted: 05/29/2024] [Indexed: 06/15/2024] Open
Abstract
Beliefs-attitudes toward some state of the environment-guide action selection and should be robust to variability but sensitive to meaningful change. Beliefs about volatility (expectation of change) are associated with paranoia in humans, but the brain regions responsible for volatility beliefs remain unknown. The orbitofrontal cortex (OFC) is central to adaptive behavior, whereas the magnocellular mediodorsal thalamus (MDmc) is essential for arbitrating between perceptions and action policies. We assessed belief updating in a three-choice probabilistic reversal learning task following excitotoxic lesions of the MDmc (n = 3) or OFC (n = 3) and compared performance with that of unoperated monkeys (n = 14). Computational analyses indicated a double dissociation: MDmc, but not OFC, lesions were associated with erratic switching behavior and heightened volatility belief (as in paranoia in humans), whereas OFC, but not MDmc, lesions were associated with increased lose-stay behavior and reward learning rates. Given the consilience across species and models, these results have implications for understanding paranoia.
Collapse
Affiliation(s)
- Praveen Suthaharan
- Interdepartmental Neuroscience Program, Yale School of Medicine, New Haven, CT, USA; Kavli Institute for Neuroscience, Yale University, New Haven, CT, USA; Department of Psychiatry, Yale University, New Haven, CT, USA
| | | | - Rosa A Rossi-Goldthorpe
- Interdepartmental Neuroscience Program, Yale School of Medicine, New Haven, CT, USA; Department of Psychiatry, Yale University, New Haven, CT, USA
| | | | - Mark E Walton
- Department of Experimental Psychology, Oxford University, Oxford, UK
| | - Subhojit Chakraborty
- Department of Experimental Psychology, Oxford University, Oxford, UK; NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London EC1V 9EL, UK
| | - Maryann P Noonan
- Department of Experimental Psychology, Oxford University, Oxford, UK; Department of Psychology, University of York, York, UK
| | - Vincent D Costa
- Division of Neuroscience, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, USA
| | | | - Christoph D Mathys
- Interacting Minds Centre, Aarhus University, Aarhus, Denmark; Translational Neuromodeling Unit (TNU), Institute for Biomedical Engineering, University of Zurich and ETH Zurich, Zurich, Switzerland
| | - Stephanie M Groman
- Department of Psychiatry, Yale University, New Haven, CT, USA; Department of Neuroscience, University of Minnesota Medical School, Minneapolis, MN, USA; Department of Anesthesia and Critical Care, University of Chicago, Chicago, IL, USA
| | - Anna S Mitchell
- Department of Experimental Psychology, Oxford University, Oxford, UK; School of Psychology, Speech, and Hearing, University of Canterbury, Christchurch, New Zealand
| | - Jane R Taylor
- Interdepartmental Neuroscience Program, Yale School of Medicine, New Haven, CT, USA; Department of Psychiatry, Yale University, New Haven, CT, USA; Department of Psychology, Yale University, New Haven, CT, USA; Wu Tsai Institute, Yale University, New Haven, CT, USA; Department of Neuroscience, Yale University, New Haven, CT, USA
| | - Philip R Corlett
- Interdepartmental Neuroscience Program, Yale School of Medicine, New Haven, CT, USA; Kavli Institute for Neuroscience, Yale University, New Haven, CT, USA; Department of Psychiatry, Yale University, New Haven, CT, USA; Department of Psychology, Yale University, New Haven, CT, USA; Wu Tsai Institute, Yale University, New Haven, CT, USA.
| | - Steve W C Chang
- Interdepartmental Neuroscience Program, Yale School of Medicine, New Haven, CT, USA; Kavli Institute for Neuroscience, Yale University, New Haven, CT, USA; Department of Psychology, Yale University, New Haven, CT, USA; Wu Tsai Institute, Yale University, New Haven, CT, USA; Department of Neuroscience, Yale University, New Haven, CT, USA.
| |
Collapse
|
3
|
Morenas-Rodríguez E, Camps-Renom P, Pérez-Cordón A, Horta-Barba A, Simón-Talero M, Cortés-Vicente E, Guisado-Alonso D, Vilaplana E, García-Sánchez C, Gironell A, Roig C, Delgado-Mederos R, Martí-Fàbregas J. Visual hallucinations in patients with acute stroke: a prospective exploratory study. Eur J Neurol 2017; 24:734-740. [PMID: 28332250 DOI: 10.1111/ene.13278] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2016] [Accepted: 02/07/2017] [Indexed: 01/30/2023]
Abstract
BACKGROUND AND PURPOSE The incidence, underlying physiopathology, features and association with lesion topography of visual hallucinations in acute stroke have scarcely been investigated. METHODS Patients with a diagnosis of acute stroke (ischaemic or haemorrhagic) in any vascular territory, admitted within 24 h after the onset of symptoms, were consecutively included in the study. Patients with a previous history of psychosis or cognitive impairment were excluded. They and/or their caregivers answered a structured hallucination and sleep questionnaire at admission, within the first 15 days and at the clinical follow-up 3-6 months after discharge. Lesion location (IMAIOS online atlas) and leukoaraiosis (Wahlund scale) were determined by magnetic resonance imaging or computed tomography scan. Subsets of patients also underwent a neuropsychological evaluation (N = 50) and an electroencephalogram (N = 33) before discharge. RESULTS In all, 77 patients with a mean age of 71 ± 12 years were included of whom 57.1% were men. The incidence of visual hallucinations was 16.7%. These hallucinations were mostly complex, in black and white and self-limited. The appearance of hallucinations was not influenced by age, sex, neuropsychological performance during admission or modified Rankin scale score at discharge. Visual hallucinations were associated with occipital cortex lesions (P = 0.04), and with sleep disturbances during and before admission (P = 0.041 and P = 0.03 respectively). CONCLUSIONS Visual hallucinations are relatively frequent in patients with acute stroke and they are self-limited. Patients with occipital lesions and sleep disturbances are more likely to suffer them.
Collapse
Affiliation(s)
- E Morenas-Rodríguez
- Department of Neurology, Biomedical Research Institute (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau (HSCSP), Barcelona, Spain
| | - P Camps-Renom
- Department of Neurology, Biomedical Research Institute (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau (HSCSP), Barcelona, Spain
| | - A Pérez-Cordón
- Department of Neurology, Biomedical Research Institute (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau (HSCSP), Barcelona, Spain
| | - A Horta-Barba
- Department of Neurology, Biomedical Research Institute (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau (HSCSP), Barcelona, Spain
| | - M Simón-Talero
- Department of Neurology, Biomedical Research Institute (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau (HSCSP), Barcelona, Spain
| | - E Cortés-Vicente
- Department of Neurology, Biomedical Research Institute (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau (HSCSP), Barcelona, Spain
| | - D Guisado-Alonso
- Department of Neurology, Biomedical Research Institute (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau (HSCSP), Barcelona, Spain
| | - E Vilaplana
- Department of Neurology, Biomedical Research Institute (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau (HSCSP), Barcelona, Spain
| | - C García-Sánchez
- Department of Neurology, Biomedical Research Institute (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau (HSCSP), Barcelona, Spain
| | - A Gironell
- Department of Neurology, Biomedical Research Institute (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau (HSCSP), Barcelona, Spain
| | - C Roig
- Department of Neurology, Biomedical Research Institute (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau (HSCSP), Barcelona, Spain
| | - R Delgado-Mederos
- Department of Neurology, Biomedical Research Institute (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau (HSCSP), Barcelona, Spain
| | - J Martí-Fàbregas
- Department of Neurology, Biomedical Research Institute (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau (HSCSP), Barcelona, Spain
| |
Collapse
|
4
|
Manganese-enhanced magnetic resonance imaging reveals increased DOI-induced brain activity in a mouse model of schizophrenia. Proc Natl Acad Sci U S A 2014; 111:E2492-500. [PMID: 24889602 DOI: 10.1073/pnas.1323287111] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
Maternal infection during pregnancy increases the risk for schizophrenia in offspring. In rodent models, maternal immune activation (MIA) yields offspring with schizophrenia-like behaviors. None of these behaviors are, however, specific to schizophrenia. The presence of hallucinations is a key diagnostic symptom of schizophrenia. In mice, this symptom can be defined as brain activation in the absence of external stimuli, which can be mimicked by administration of hallucinogens. We find that, compared with controls, adult MIA offspring display an increased stereotypical behavioral response to the hallucinogen 2,5-dimethoxy-4-iodoamphetamine (DOI), an agonist for serotonin receptor 2A (5-HT2AR). This may be explained by increased levels of 5-HT2AR and downstream signaling molecules in unstimulated MIA prefrontal cortex (PFC). Using manganese-enhanced magnetic resonance imaging to identify neuronal activation elicited by DOI administration, we find that, compared with controls, MIA offspring exhibit a greater manganese (Mn(2+)) accumulation in several brain areas, including the PFC, thalamus, and striatum. The parafascicular thalamic nucleus, which plays the role in the pathogenesis of hallucinations, is activated by DOI in MIA offspring only. Additionally, compared with controls, MIA offspring demonstrate higher DOI-induced expression of early growth response protein 1, cyclooxygenase-2, and brain-derived neurotrophic factor in the PFC. Chronic treatment with the 5-HT2AR antagonist ketanserin reduces DOI-induced head twitching in MIA offspring. Thus, the MIA mouse model can be successfully used to investigate activity induced by DOI in awake, behaving mice. Moreover, manganese-enhanced magnetic resonance imaging is a useful, noninvasive method for accurately measuring this type of activity.
Collapse
|